Neuroblastoma, a devastating pediatric malignancy, remains one of the most challenging childhood cancers despite decades of therapeutic advancements. This extracranial...

In a groundbreaking advancement poised to reshape the landscape of liver cancer treatment, researchers at UCLA have embarked on an...

At the intersection of oncology and artificial intelligence, researchers at the Medical University of South Carolina’s Hollings Cancer Center have...

The University of Texas at San Antonio (UTSA) and its academic health center, UT Health San Antonio, have recently been...

Neuroendocrine prostate cancer (NEPC) represents one of the most formidable challenges in oncology today, owing to its aggressive behavior, resistance...

A groundbreaking theranostic strategy targeting RET, an emergent biomarker specific to neuroendocrine prostate cancer (NEPC), promises to revolutionize the diagnosis...

A groundbreaking advancement in molecular imaging has emerged from recent clinical research, unveiling a novel PET tracer that targets carbonic...

A groundbreaking advancement in the realm of metastatic castration-resistant prostate cancer (mCRPC) therapy has emerged from a recent study involving...

A groundbreaking investigation into the ramifications of population-based multicancer early detection (MCED) screening trials has shed new light on the...

In a bold leap toward precision oncology, researchers have proposed an innovative adeno-associated virus (AAV) vector system engineered to selectively...